Long-term Efficacy of Filgotinib Monotherapy and Combination Therapy: Interim Results from a Post Hoc Analysis of the FINCH 4 Study

被引：0
|
作者：
Buch, Maya H. [1 ,2 ]
Verschueren, Patrick [3 ,4 ]
Caporali, Roberto [5 ,6 ]
Huizinga, Thomas [7 ]
Omoruyi, Edmund V. Ekoka [8 ]
de Vries, Dick [9 ]
Ritsema, Jeffrey [10 ]
De Leonardis, Francesco [11 ]
Aletaha, Daniel [12 ]
机构：
[1] Univ Manchester, Div Musculoskeletal & Dermatol Sci, Manchester, Lancs, England
[2] NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England
[3] Univ Hosp Leuven, Dept Rheumatol, Leuven, Belgium
[4] Katholieke Univ Leuven, Leuven, Belgium
[5] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[6] ASST Gaetano Pini CTO, Dept Rheumatol & Med Sci, Milan, Italy
[7] Leiden Univ, Dept Rheumatol, Leiden, Netherlands
[8] Galapagos NV, Biostat, Mechelen, Belgium
[9] Galapagos BV, Clin Dev, Leiden, Netherlands
[10] Galapagos BV, Med Affairs, Leiden, Netherlands
[11] Galapagos GmbH, Med Affairs, Basel, Switzerland
[12] Med Univ Vienna, Div Rheumatol, Dept Med 3, Vienna, Austria
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2252
引用
收藏
页码：4531 / 4534
页数：4
相关论文
共 50 条
  • [21] LONG-TERM SAFETY AND EFFICACY OF 4-WEEKLY CERTOLIZUMAB PEGOL MONOTHERAPY AND COMBINATION THERAPY IN RHEUMATOID ARTHRITIS: 5-YEAR RESULTS FROM AN OPEN-LABEL EXTENSION STUDY
    Fleischmann, R.
    van Vollenhoven, R.
    Vencovsky, J.
    Alten, R.
    Davies, O.
    Stach, C.
    de Longueville, M.
    VanLunen, B.
    Choy, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 435 - 435
  • [22] Barnidipine monotherapy and combination therapy in older patients with essential hypertension:: A long-term study
    Naber, FB
    Häge, R
    Mortelmans, J
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, : 27 - 35
  • [23] Fremanezumab Long-Term Efficacy and Safety: Interim Results of a One-Year Study
    Goadsby, P.
    Yeung, P. P.
    Blankenbiller, T.
    Grozinski-Wolff, M.
    Yang, R.
    Ma, Y.
    Ning, X.
    Aycardi, E.
    HEADACHE, 2018, 58 : 166 - 166
  • [24] Efficacy and safety outcomes of long-term treatment with filgotinib 200 mg among patients with Ulcerative Colitis: An interim analysis of SELECTIONLTE
    Feagan, B. G.
    Matsuoka, K.
    Rogler, G.
    Faes, M.
    Oortwijn, A.
    de Haas, A.
    Rudolph, C.
    Patel, H.
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I456 - I457
  • [25] Efficacy and safety outcomes of long-term treatment with filgotinib 200 mg among patients with Ulcerative Colitis: An interim analysis of SELECTIONLTE
    Matsuoka, K.
    Rogler, G.
    Faes, M.
    Oortwijn, A.
    de Haas, A.
    Rudolph, C.
    Patel, H.
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I456 - I457
  • [26] Long-Term Safety and Efficacy of 4-Weekly Certolizumab Pegol Combination and Monotherapy in Rheumatoid Arthritis: 5 Year Results from an Open Label Extension Study
    Fleischmann, Roy M.
    van Vollenhoven, Ronald F.
    Vencovsky, Jiri
    Alten, Rieke
    Davies, Owen
    Stach, Christian
    de Longueville, Marc
    Van Lunen, Brenda
    Choy, Ernest
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S565 - S566
  • [27] A post hoc analysis of the long-term safety and efficacy of perampanel in Asian patients with epilepsy
    Inoue, Yushi
    Kaneko, Sunao
    Hsieh, Peiyuan F.
    Meshram, Chandrashekhar
    Lee, Sang-Ahm
    Aziz, Zariah Abdul
    Nabangchang, Charcrin
    Dash, Amitabh
    EPILEPSIA, 2019, 60 : 60 - 67
  • [28] Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study
    Combe, Bernard G.
    Tanaka, Yoshiya
    Buch, Maya H.
    Nash, Peter
    Burmester, Gerd R.
    Kivitz, Alan J.
    Bartok, Beatrix
    Pechonkina, Alena
    Xia, Katrina
    Emoto, Kahaku
    Kano, Shungo
    Hendrikx, Thijs K.
    Landewe, Robert B. M.
    Aletaha, Daniel
    RHEUMATOLOGY AND THERAPY, 2023, 10 (01) : 53 - 70
  • [29] Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study
    Bernard G. Combe
    Yoshiya Tanaka
    Maya H. Buch
    Peter Nash
    Gerd R. Burmester
    Alan J. Kivitz
    Beatrix Bartok
    Alena Pechonkina
    Katrina Xia
    Kahaku Emoto
    Shungo Kano
    Thijs K. Hendrikx
    Robert B. M. Landewé
    Daniel Aletaha
    Rheumatology and Therapy, 2023, 10 : 53 - 70
  • [30] Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naive to MTX treatment (FINCH 3)
    Atsumi, Tatsuya
    Tanaka, Yoshiya
    Matsubara, Tsukasa
    Amano, Koichi
    Ishiguro, Naoki
    Sugiyama, Eiji
    Yamaoka, Kunihiro
    Westhovens, Rene
    Ching, Daniel W. T.
    Messina, Osvaldo Daniel
    Burmester, Gerd R.
    Genovese, Mark
    Bartok, Beatrix
    Pechonkina, Alena
    Kondo, Akira
    Yin, Zhaoyu
    Gong, Qi
    Tasset, Chantal
    Takeuchi, Tsutomu
    MODERN RHEUMATOLOGY, 2023, 33 (04) : 657 - 667
12345